Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

PHASE4CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

March 2, 2024

Primary Completion Date

February 11, 2025

Study Completion Date

February 11, 2025

Conditions
Japanese EncephalitisMeaslesMumpsRubella
Interventions
BIOLOGICAL

Vero cell-drived inactive Japanese encephalitis vaccine

0.5ml for each dose, manufactured by Liaoning Chengda Biotechnology CO., LTD, administered in the deltoid area of lateral arm by intramuscular injection.

BIOLOGICAL

Measles-Mumps-Rubella Vaccine

0.5ml for each dose (after dissolving), manufactured by Shanghai Institute of Biological Products CO., LTD, administered in the lower part of the deltoid area of lateral arm, by subcutaneous injection.

Trial Locations (1)

210009

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing

All Listed Sponsors
lead

Liaoning Chengda Biotechnology CO., LTD

INDUSTRY

NCT06331702 - Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) | Biotech Hunter | Biotech Hunter